Previously, Eisenberg et al. employed a truncated soluble version of the SLAMF6 ectodomain to boost amplification, cytokine secretion, and cytolytic capacity of melanoma-specific CD8+ T cells [29]. The gene discussed is CD8A; the disease is melanoma.